共同药业：关于共同转债预计触发转股价格向下修正条件的提示性公告

Core Viewpoint - The company announced that its stock price has been below 85% of the current conversion price for ten trading days, which may trigger a downward adjustment of the conversion price [1] Group 1 - The announcement was made on September 16, indicating a potential adjustment period from September 3 to September 16, 2025 [1] - The company will follow the relevant regulations outlined in the Shenzhen Stock Exchange's self-regulatory guidelines and the prospectus if the adjustment condition is triggered [1] - Investors are advised to pay attention to investment risks associated with this potential adjustment [1]